Thomas Meth - 01 Mar 2023 Form 4 Insider Report for Enviva Inc.

Role
President and CEO, Director
Signature
/s/ Jason E. Paral, as attorney-in-fact for Thomas Meth
Issuer symbol
N/A
Transactions as of
01 Mar 2023
Net transactions value
+$499,997
Form type
4
Filing time
03 Mar 2023, 18:19:00 UTC
Previous filing
28 Feb 2023
Next filing
07 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVA Series A Preferred Stock Award $499,997 +13,259 $37.71* 13,259 01 Mar 2023 Common Stock 13,259 $37.71 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock ("Preferred Share") is convertible into one share of Common Stock of Enviva Inc. (the "Issuer"), subject to adjustment for any stock dividends, splits, combinations, and similar events.
F2 The conversion of the Preferred Shares to shares of Common Stock of the Issuer is subject to and will occur automatically upon stockholder approval of a proposal to issue Common Stock upon conversion of the Preferred Shares for purposes of Rule 312.03 of the New York Stock Exchange Listed Company Manual.